SloveniaJohnson & Johnson has proposed a settlement worth up to $5.5 billion to resolve thousands of lawsuits in the United States over claims that its baby powder and other talcum products caused ovarian cancer. The company denies the allegations but has changed the composition of its baby powder. The proposed settlement would cover approximately 69,000 cases and involve payments of up to $3 billion by next year, with additional payments potentially occurring before 2028. The settlement requires approval from law firms representing at least 95% of the claims. The legal dispute dates back to 2009, and the U.S. federal court recently ruled in favor of Johnson & Johnson, casting doubt on whether talc directly causes ovarian cancer. The company faces similar claims outside North America through its subsidiary Kenvue, which was spun off in 2022.
Bias read (Center): The article presents the situation objectively, citing both the company's denial of the allegations and the claims made by plaintiffs. It does not show clear bias toward either side, providing information on the proposed settlement, the legal proceedings, and the company's stance without overtly slm
